KinetiSol® Technology: Scale Up Approach

This presentation features Justin Keen, Senior Vice President of Operations at AustinPx, sharing more about KinetiSol technology, a revolutionary approach to creating amorphous solid dispersions. Learn how KinetiSol tackles the challenges of developing drugs with poor solubility.

Keen discusses how process development goals adapt as your product progresses, ensuring efficient manufacturing for both clinical trials and commercial production. Real-world examples illustrate the relationship between process parameters and the final product's quality.

Learn more about:

• Enhanced Bioavailability: Increase the absorption of poorly soluble drugs.
• Faster Development: KinetiSol's solvent-free, fusion-based process saves valuable time.
• Next-Generation Technology: Experience a groundbreaking approach to amorphous dispersion manufacturing.